Evidence map›Paper›PMID 34837627›Full record

ReviewMolecular biology reports2022

Multiple microRNA signature panel as promising potential for diagnosis and prognosis of head and neck cancer.

Sethu Thakachy Subha, Jun Wei Chin, Yoke Kqueen Cheah, Norhafizah Mohtarrudin, Hasni Idayu Saidi

Open access · hybridAbstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sethu Thakachy Subha *Department of Otorhinolaryngology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia. sethu@upm.edu.my.ORCID http://orcid.org/0000-0002-2156-9840
Jun Wei ChinDepartment of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia.ORCID http://orcid.org/0000-0002-1216-7487
Yoke Kqueen Cheah *Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia.ORCID http://orcid.org/0000-0001-9258-3749
Norhafizah MohtarrudinDepartment of Pathology, Faculty of Medicine and Health Sciences, University Putra Malaysia, 43400, Serdang, Selangor, Malaysia.ORCID http://orcid.org/0000-0003-0084-6025
Hasni Idayu SaidiDepartment of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia.ORCID http://orcid.org/0000-0002-6262-5634
Universiti Putra Malaysia · MY

Funding

Fakulti Perubatan dan Sains Kesihatan, Universiti Putra Malaysia GP/2018/9613000Kementerian Pendidikan MALAYSIA 04-01-20-2285FR
6 · The paper itself

Abstract

MicroRNAs are small non-coding RNA that regulate gene expressions of human body. To date, numerous studies have reported that microRNAs possess great diagnostic and prognostic power in head and neck cancer and had governed a lot of attention. The factor for the successfulness of miRNAs in these aspects is due to cancer being fundamentally tied to genetic changes, which are regulated by these miRNAs. Head and neck cancer, leading the world record for cancer as number sixth, is caused by multiple risk factors such as tobacco consumption, alcohol consumption, dietary factors, ethnicity, family history, and human papilloma virus. It derives at locations such as oral cavity, pharynx, larynx, paranasal sinus and salivary gland and have high rate of mortality with high recurrence rate. Besides, head and neck cancer is also usually having poor prognosis due to its asymptomatic nature. However, this diagnostic and prognostic power can be further improved by using multiple panels of miRNA as a signature or even combined with TNM staging system to obtain even more remarkable results. This is due to multiple factors such as tumour heterogeneity and components of the tumour which may affect the composition of miRNAs. This review covers the examples of such miRNA signatures, compare their diagnostic and prognostic powers, discuss some controversial roles of unreported miRNAs, and the molecular mechanisms of the miRNAs in gene targeting and pathways.

Indexed as

Biomarkers, TumorCarcinoma, Squamous CellGene ExpressionGene Expression ProfilingGene Expression Regulation, NeoplasticHead and Neck NeoplasmsHumansMicroRNAsNeoplasm StagingPapillomaviridaePrognosisSquamous Cell Carcinoma of Head and NeckTranscriptomeBiomarkers, TumorMicroRNAsBiomarkerDiagnosisHead and neck squamous cell carcinoma (HNSCC)miRNAPrognosis

Identifiers

PMID34837627
OpenAlexW3217283046

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.